<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02768493</url>
  </required_header>
  <id_info>
    <org_study_id>4-2016-0192</org_study_id>
    <nct_id>NCT02768493</nct_id>
  </id_info>
  <brief_title>Ultrasonographic Assessment of Optic Nerve Sheath Diameter in Children Receiving Caudal Block</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The recent study revealed that high-volume caudal block caused reduction in cerebral blood
      flow velocity and cerebral oxygenation. It was supposed to be associated with increased
      intracranial pressure. Ultrasonography of optic nerve sheath diameter shows a good level of
      diagnostic accuracy for detecting intracranial hypertension. The aim of this study is to
      evaluate the effect of caudal block on intracranial pressure in pediatric patients undergoing
      urologic surgery. Eighty patients, aged 6 months to 4 years, receiving caudal block before
      urologic surgery will be divided into high dose group (n=40) and low dose group (n=40).
      Randomly selected patients of the high dose group are given 1.5 ml/kg of 0.15% ropivacaine
      for caudal block. In contrast, patients in the low dose group are given 1.0 ml/kg of 0.15%
      ropivacaine for caudal block. The primary endpoint is the optic nerve sheath diameter after
      caudal block measured by optic nerve ultrasonography.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The difference in the optic nerve sheath diameter between groups</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The variation in the optic nerve sheath diameter before and after caudal block</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the difference in the variation of the optic nerve sheath diameter between groups</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Orchiopexy</condition>
  <condition>Inguinal Hernioplasty</condition>
  <condition>Hydrocelectomy</condition>
  <condition>Diverticulectomy</condition>
  <condition>Fistula Repair</condition>
  <condition>Penoplasty</condition>
  <arm_group>
    <arm_group_label>low dose group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in the low dose group are given 1.0 ml/kg of 0.15% ropivacaine for caudal block.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high dose group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in the high dose group are given 1.5 ml/kg of 0.15% ropivacaine for caudal block.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>1.0 ml/kg of 0.15% ropivacaine</intervention_name>
    <description>Randomly selected patients of the high dose group are given 1.5 ml/kg of 0.15% ropivacaine for caudal block before their surgery. In contrast, patients in the low dose group are given 1.0 ml/kg of 0.15% ropivacaine for caudal block before surgery.</description>
    <arm_group_label>low dose group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>1.5 ml/kg of 0.15% ropivacaine</intervention_name>
    <description>Randomly selected patients of the high dose group are given 1.5 ml/kg of 0.15% ropivacaine for caudal block before their surgery. In contrast, patients in the low dose group are given 1.0 ml/kg of 0.15% ropivacaine for caudal block before surgery.</description>
    <arm_group_label>high dose group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pediatric patients

          -  weighing less than 16 kg

          -  who receive caudal block before urologic surgery

        Exclusion Criteria:

          -  Subjects are ineligible if they have contraindication for caudal block such as
             infection, coagulopathy, anomaly, or past medical history related to increased
             intracranial pressure

          -  ophthalmic disease

          -  expected operation time is less than 30 minutes

          -  both parents are unable to communicate or speak Korean.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>4 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei universiy college of medicine</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Girisgin AS, Kalkan E, Kocak S, Cander B, Gul M, Semiz M. The role of optic nerve ultrasonography in the diagnosis of elevated intracranial pressure. Emerg Med J. 2007 Apr;24(4):251-4.</citation>
    <PMID>17384377</PMID>
  </reference>
  <reference>
    <citation>Dubourg J, Javouhey E, Geeraerts T, Messerer M, Kassai B. Ultrasonography of optic nerve sheath diameter for detection of raised intracranial pressure: a systematic review and meta-analysis. Intensive Care Med. 2011 Jul;37(7):1059-68. doi: 10.1007/s00134-011-2224-2. Epub 2011 Apr 20. Review.</citation>
    <PMID>21505900</PMID>
  </reference>
  <reference>
    <citation>Dubost C, Le Gouez A, Jouffroy V, Roger-Christoph S, Benhamou D, Mercier FJ, Geeraerts T. Optic nerve sheath diameter used as ultrasonographic assessment of the incidence of raised intracranial pressure in preeclampsia: a pilot study. Anesthesiology. 2012 May;116(5):1066-71. doi: 10.1097/ALN.0b013e318246ea1a.</citation>
    <PMID>22258019</PMID>
  </reference>
  <reference>
    <citation>Lundblad M, Forestier J, Marhofer D, Eksborg S, Winberg P, Lönnqvist PA. Reduction of cerebral mean blood flow velocity and oxygenation after high-volume (1.5 ml kg⁻¹) caudal block in infants. Br J Anaesth. 2014 Oct;113(4):688-94. doi: 10.1093/bja/aeu161. Epub 2014 Jun 27.</citation>
    <PMID>24972788</PMID>
  </reference>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2016</study_first_submitted>
  <study_first_submitted_qc>May 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2016</study_first_posted>
  <last_update_submitted>September 7, 2016</last_update_submitted>
  <last_update_submitted_qc>September 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

